A pooled analysis of third-line placebo-controlled trials from the ARCAD CRC Database evaluated the prognostic impact of liver metastases and KRAS mutations in metastatic colorectal cancer patients. (Clinical Colorectal Cancer)
Pooled Analysis Examines Prognostic Value of KRAS Mutations and Liver Metastases
The CRC Digest